Description
OX-L – 3p 20 (Retatrutide 20mg) is a precision-manufactured research compound formulated for intermediate-volume laboratory investigations involving GLP-1, GIP, and glucagon triple receptor mechanisms. The 20mg format supports researchers requiring greater compound availability for multi-cycle protocols, comparative studies, and extended receptor interaction investigations.
Each unit undergoes rigorous third-party laboratory testing and is supplied with a Certificate of Analysis (COA) verifying compound identity, purity, and batch-to-batch consistency, critical standards for professional research environments.
Compound Overview
Retatrutide operates as a triagonist research peptide, engaging GLP-1, GIP, and glucagon receptors simultaneously. This multi-receptor interaction profile positions it as a highly relevant compound for researchers studying metabolic pathways, energy regulation mechanisms, and endocrine system dynamics across multiple receptor classes in a single research model.

Reviews
There are no reviews yet.